Forte Biosciences, Inc. Common Stock

FBRX XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

370M

Short interest (May 15)

5.9%

Net Short (Jun 03 ): -0.1%

Borrow Fee

1.33%

↓ 33.9%

Available Shares

500K

↑ 2.9%

Price Chart

Company Overview

Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001419041

Asset Type: CS

Market Data

Market Cap: $372,202,498

Employees: 22

Status: Active

Short Interest

Current Borrow Fee 1.33%

Range: 1.33% - 1.38%

Available Shares 500K

Range: 500K - 750K

Recent Changes

Fee Change: ↓ 8.2%

Available Change: ↑ 4.2%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime